UCSF's Pilot Award for Young-Onset Colorectal Cancer funds innovative research into the biology, prevention, diagnosis, care, and survivorship of colorectal cancer in people under 50.
Funder: University of California San Francisco
Due Dates (Anticipated): October 2026 (Fall Cycle, projected) | March 2027 (Spring Cycle, projected)
Funding Amounts: Up to $100,000 per award; project duration 12–24 months; not renewable.
Summary: Supports innovative research on young-onset colorectal cancer in individuals under 50, spanning biology, prevention, diagnosis, care, and survivorship.
This award, administered by the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, is designed to foster research that advances the understanding, prevention, diagnosis, clinical care, and survivorship of colorectal cancer diagnosed in individuals under age 50. The program encourages innovative projects across clinical, basic, translational, and population health research, with particular emphasis on disease biology, risk factors, early detection, precision medicine, survivorship, and health equity.
Priority research areas include:
Projects may be clinical, basic/translational, or population science in nature. The award is intended to generate preliminary data and support the development of larger, externally funded research programs.